WallStreetZenWallStreetZen

NASDAQ: RSLS
Reshape Lifesciences Revenue

OverviewEarningsRevenue
DividendOwnership
Reshape Lifesciences revenue was $8.01M for the trailing 12 months ending Dec 31, 2024, with N/A growth year over year. Quarterly revenue for the quarter (Q4 2024) ending on Dec 31, 2024 was $1.8M, down 21.2% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, RSLS annual revenue was $8.0M, with -7.7% growth year-over-year.

RSLS past revenue growth

How has RSLS's revenue growth performed historically?

Company
-7.74%
Industry
10.53%
Market
20.68%
RSLS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
RSLS's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
RSLS's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

RSLS revenue history

Current Revenue
$8.0M
Current Earnings
-$7.1M
Current Profit Margin
-89.1%

Be the first to know when RSLS announces revenue.

RSLS Revenue History By Year

RSLS Yearly RevenueRSLS RevenueRSLS ChangeRSLS Revenue Growth
2024-12-31$8.01M-$672.00k-7.74%
2023-12-31$8.68M-$2.56M-22.79%
2022-12-31$11.24M-$2.36M-17.35%
2021-12-31$13.60M$2.30M+20.36%
2020-12-31$11.30M$8.02M+244.38%
2019-12-31$3.28M-$5.82M-63.95%
2018-12-31$9.10M-$813.00k-8.20%
2017-12-31$9.91M$6.52M+192.19%
2016-12-31$3.39M-$646.00k-15.99%
2015-12-31$4.04M$500.00k+14.13%
2014-12-31$3.54MN/AN/A

1 of 1

Reshape Lifesciences Revenue FAQ

What was RSLS's revenue last quarter?

On Invalid Date, Reshape Lifesciences (NASDAQ: RSLS) reported Q4 2024 revenue of $1.81 million up 8.93% year over year. In the same quarter last year, Reshape Lifesciences's revenue was $1.98 million.

What was Reshape Lifesciences's revenue in 2024?

Reshape Lifesciences's annual revenue for the twelve months ending Dec 31, 2024 was $8.01 million, a 7.74% decrease year over year.

How much does Reshape Lifesciences make in a day?

Based on Reshape Lifesciences annual revenue for the past five years, RSLS makes an average of $28,944.11 per day.

What was Reshape Lifesciences's annual revenue growth in the past year?

As of Q2 2025, Reshape Lifesciences's revenue has grown -7.74% year over year. This is 18.27 percentage points lower than the US Medical Devices industry revenue growth rate of 10.53%. Reshape Lifesciences's revenue in the past year totaled $8.01 million.

How much does Reshape Lifesciences make in a year?

Reshape Lifesciences's revenue by year for the past five years is:
  • Reshape Lifesciences's revenue for the twelve months ending Dec 31, 2024 was $8.01 million, a 7.74% decrease year over year.
  • Reshape Lifesciences's annual revenue for Dec 31, 2023 was $8.68 million, a 22.79% decrease from 2022.
  • Reshape Lifesciences's annual revenue for 2022 was $11.24 million, a 17.35% decrease from 2021.
  • Reshape Lifesciences's annual revenue for 2021 was $13.60 million, a 20.36% increase from 2020.
  • Reshape Lifesciences's annual revenue for 2020 was $11.30 million, a 244.38% increase from 2019.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.